This article has Open Peer Review reports available.
Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy
© The Author(s). 2017
Received: 4 April 2017
Accepted: 22 August 2017
Published: 11 September 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|4 Apr 2017||Submitted||Original manuscript|
|9 Jun 2017||Reviewed||Reviewer Report - Davide Pareyson|
|30 Jun 2017||Reviewed||Reviewer Report - Laura Obici|
|2 Aug 2017||Author responded||Author comments - David Adams|
|Resubmission - Version 2|
|2 Aug 2017||Submitted||Manuscript version 2|
|21 Aug 2017||Author responded||Author comments - David Adams|
|Resubmission - Version 3|
|21 Aug 2017||Submitted||Manuscript version 3|
|22 Aug 2017||Editorially accepted|
|11 Sep 2017||Article published||10.1186/s12883-017-0948-5|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.